CN114606173A - 重组大肠杆菌klugin73及其应用 - Google Patents
重组大肠杆菌klugin73及其应用 Download PDFInfo
- Publication number
- CN114606173A CN114606173A CN202210349185.1A CN202210349185A CN114606173A CN 114606173 A CN114606173 A CN 114606173A CN 202210349185 A CN202210349185 A CN 202210349185A CN 114606173 A CN114606173 A CN 114606173A
- Authority
- CN
- China
- Prior art keywords
- klugin73
- escherichia coli
- recombinant
- icariin
- fermentation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000588724 Escherichia coli Species 0.000 title claims abstract description 59
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 claims abstract description 53
- TZJALUIVHRYQQB-XFDQAQKOSA-N Icariin Natural products O(C)c1ccc(C2=C(O[C@H]3[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)C(=O)c3c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)c(C/C=C(\C)/C)c3O2)cc1 TZJALUIVHRYQQB-XFDQAQKOSA-N 0.000 claims abstract description 50
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 claims abstract description 50
- 238000006243 chemical reaction Methods 0.000 claims abstract description 33
- 102000004190 Enzymes Human genes 0.000 claims abstract description 28
- 108090000790 Enzymes Proteins 0.000 claims abstract description 28
- TUUXBSASAQJECY-UHFFFAOYSA-N 3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-(3-methylbut-2-enyl)chromen-4-one Chemical compound C1=CC(OC)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C(CC=C(C)C)=C2O1 TUUXBSASAQJECY-UHFFFAOYSA-N 0.000 claims abstract description 27
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 25
- 230000007062 hydrolysis Effects 0.000 claims abstract description 22
- 238000000034 method Methods 0.000 claims abstract description 20
- 102000005744 Glycoside Hydrolases Human genes 0.000 claims abstract description 19
- 108010031186 Glycoside Hydrolases Proteins 0.000 claims abstract description 19
- 239000000758 substrate Substances 0.000 claims abstract description 18
- CTGVBHDTGZUEJZ-UHFFFAOYSA-N Noricaritin Natural products CC(C)(O)CCC1=C(O)C=C(O)C(C(C=2O)=O)=C1OC=2C1=CC=C(O)C=C1 CTGVBHDTGZUEJZ-UHFFFAOYSA-N 0.000 claims abstract description 13
- 230000008569 process Effects 0.000 claims abstract description 8
- 238000004321 preservation Methods 0.000 claims abstract description 7
- 238000000855 fermentation Methods 0.000 claims description 37
- 230000004151 fermentation Effects 0.000 claims description 37
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 20
- 238000004519 manufacturing process Methods 0.000 claims description 18
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 claims description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 10
- 238000012258 culturing Methods 0.000 claims description 8
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 5
- 229910052799 carbon Inorganic materials 0.000 claims description 5
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 4
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 4
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 4
- 229940041514 candida albicans extract Drugs 0.000 claims description 4
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 claims description 4
- 229910000396 dipotassium phosphate Inorganic materials 0.000 claims description 4
- 235000019797 dipotassium phosphate Nutrition 0.000 claims description 4
- 238000011081 inoculation Methods 0.000 claims description 4
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 4
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 4
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 239000012137 tryptone Substances 0.000 claims description 4
- 239000012138 yeast extract Substances 0.000 claims description 4
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims description 3
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims description 3
- 230000003213 activating effect Effects 0.000 claims description 3
- 230000006698 induction Effects 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000002773 nucleotide Substances 0.000 claims description 2
- 125000003729 nucleotide group Chemical group 0.000 claims description 2
- 239000000047 product Substances 0.000 abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 9
- 230000003301 hydrolyzing effect Effects 0.000 abstract description 8
- 239000006227 byproduct Substances 0.000 abstract description 5
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 abstract description 4
- 238000001228 spectrum Methods 0.000 abstract description 4
- 229930182478 glucoside Natural products 0.000 abstract description 2
- 150000008131 glucosides Chemical class 0.000 abstract description 2
- 150000008265 rhamnosides Chemical class 0.000 abstract description 2
- 125000000600 disaccharide group Chemical group 0.000 abstract 1
- 229940088598 enzyme Drugs 0.000 description 24
- 239000002609 medium Substances 0.000 description 11
- 238000005457 optimization Methods 0.000 description 9
- 241001138401 Kluyveromyces lactis Species 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 6
- 239000012634 fragment Substances 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 6
- 239000008055 phosphate buffer solution Substances 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 238000000246 agarose gel electrophoresis Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 241000893536 Epimedium Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 241001052560 Thallis Species 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 3
- 238000001976 enzyme digestion Methods 0.000 description 3
- 235000018905 epimedium Nutrition 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 229930027917 kanamycin Natural products 0.000 description 3
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 3
- 229960000318 kanamycin Drugs 0.000 description 3
- 229930182823 kanamycin A Natural products 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 2
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 2
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 2
- CDKZJGMPZHPAJC-ULQDDVLXSA-N Tyr-Leu-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 CDKZJGMPZHPAJC-ULQDDVLXSA-N 0.000 description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 description 2
- 108010005233 alanylglutamic acid Proteins 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000007071 enzymatic hydrolysis Effects 0.000 description 2
- -1 flavonoid glycoside compounds Chemical class 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 2
- 108010050848 glycylleucine Proteins 0.000 description 2
- 108010081551 glycylphenylalanine Proteins 0.000 description 2
- 108010009298 lysylglutamic acid Proteins 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000012064 sodium phosphate buffer Substances 0.000 description 2
- AXFMEGAFCUULFV-BLFANLJRSA-N (2s)-2-[[(2s)-1-[(2s,3r)-2-amino-3-methylpentanoyl]pyrrolidine-2-carbonyl]amino]pentanedioic acid Chemical compound CC[C@@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O AXFMEGAFCUULFV-BLFANLJRSA-N 0.000 description 1
- 101150096372 1.3 gene Proteins 0.000 description 1
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- YLTKNGYYPIWKHZ-ACZMJKKPSA-N Ala-Ala-Glu Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O YLTKNGYYPIWKHZ-ACZMJKKPSA-N 0.000 description 1
- NHCPCLJZRSIDHS-ZLUOBGJFSA-N Ala-Asp-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O NHCPCLJZRSIDHS-ZLUOBGJFSA-N 0.000 description 1
- PBAMJJXWDQXOJA-FXQIFTODSA-N Ala-Asp-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N PBAMJJXWDQXOJA-FXQIFTODSA-N 0.000 description 1
- IKKVASZHTMKJIR-ZKWXMUAHSA-N Ala-Asp-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O IKKVASZHTMKJIR-ZKWXMUAHSA-N 0.000 description 1
- CCDFBRZVTDDJNM-GUBZILKMSA-N Ala-Leu-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O CCDFBRZVTDDJNM-GUBZILKMSA-N 0.000 description 1
- SDZRIBWEVVRDQI-CIUDSAMLSA-N Ala-Lys-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O SDZRIBWEVVRDQI-CIUDSAMLSA-N 0.000 description 1
- 108010011667 Ala-Phe-Ala Proteins 0.000 description 1
- XRUJOVRWNMBAAA-NHCYSSNCSA-N Ala-Phe-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 XRUJOVRWNMBAAA-NHCYSSNCSA-N 0.000 description 1
- IPZQNYYAYVRKKK-FXQIFTODSA-N Ala-Pro-Ala Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O IPZQNYYAYVRKKK-FXQIFTODSA-N 0.000 description 1
- RMAWDDRDTRSZIR-ZLUOBGJFSA-N Ala-Ser-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O RMAWDDRDTRSZIR-ZLUOBGJFSA-N 0.000 description 1
- BGGAIXWIZCIFSG-XDTLVQLUSA-N Ala-Tyr-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O BGGAIXWIZCIFSG-XDTLVQLUSA-N 0.000 description 1
- DEAGTWNKODHUIY-MRFFXTKBSA-N Ala-Tyr-Trp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O DEAGTWNKODHUIY-MRFFXTKBSA-N 0.000 description 1
- IYKVSFNGSWTTNZ-GUBZILKMSA-N Ala-Val-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IYKVSFNGSWTTNZ-GUBZILKMSA-N 0.000 description 1
- CYXCAHZVPFREJD-LURJTMIESA-N Arg-Gly-Gly Chemical compound NC(=N)NCCC[C@H](N)C(=O)NCC(=O)NCC(O)=O CYXCAHZVPFREJD-LURJTMIESA-N 0.000 description 1
- ZZZWQALDSQQBEW-STQMWFEESA-N Arg-Gly-Tyr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZZZWQALDSQQBEW-STQMWFEESA-N 0.000 description 1
- MMGCRPZQZWTZTA-IHRRRGAJSA-N Arg-His-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N MMGCRPZQZWTZTA-IHRRRGAJSA-N 0.000 description 1
- BTJVOUQWFXABOI-IHRRRGAJSA-N Arg-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCNC(N)=N BTJVOUQWFXABOI-IHRRRGAJSA-N 0.000 description 1
- DNLQVHBBMPZUGJ-BQBZGAKWSA-N Arg-Ser-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O DNLQVHBBMPZUGJ-BQBZGAKWSA-N 0.000 description 1
- OWUCNXMFJRFOFI-BQBZGAKWSA-N Asn-Gly-Met Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CCSC)C(O)=O OWUCNXMFJRFOFI-BQBZGAKWSA-N 0.000 description 1
- GJFYPBDMUGGLFR-NKWVEPMBSA-N Asn-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CC(=O)N)N)C(=O)O GJFYPBDMUGGLFR-NKWVEPMBSA-N 0.000 description 1
- NKLRWRRVYGQNIH-GHCJXIJMSA-N Asn-Ile-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O NKLRWRRVYGQNIH-GHCJXIJMSA-N 0.000 description 1
- YYSYDIYQTUPNQQ-SXTJYALSSA-N Asn-Ile-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O YYSYDIYQTUPNQQ-SXTJYALSSA-N 0.000 description 1
- HMUKKNAMNSXDBB-CIUDSAMLSA-N Asn-Met-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(O)=O HMUKKNAMNSXDBB-CIUDSAMLSA-N 0.000 description 1
- RYEWQKQXRJCHIO-SRVKXCTJSA-N Asp-Asn-Tyr Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 RYEWQKQXRJCHIO-SRVKXCTJSA-N 0.000 description 1
- YDJVIBMKAMQPPP-LAEOZQHASA-N Asp-Glu-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O YDJVIBMKAMQPPP-LAEOZQHASA-N 0.000 description 1
- KTTCQQNRRLCIBC-GHCJXIJMSA-N Asp-Ile-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O KTTCQQNRRLCIBC-GHCJXIJMSA-N 0.000 description 1
- VSMYBNPOHYAXSD-GUBZILKMSA-N Asp-Lys-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O VSMYBNPOHYAXSD-GUBZILKMSA-N 0.000 description 1
- FIRWLDUOFOULCA-XIRDDKMYSA-N Asp-Trp-Lys Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)O)N FIRWLDUOFOULCA-XIRDDKMYSA-N 0.000 description 1
- KBWLCLABEAMUIU-DJESZUOASA-N Asp-Trp-Trp-Val Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](CC=3C4=CC=CC=C4NC=3)C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@@H](N)CC(O)=O)=CNC2=C1 KBWLCLABEAMUIU-DJESZUOASA-N 0.000 description 1
- KNDCWFXCFKSEBM-AVGNSLFASA-N Asp-Tyr-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O KNDCWFXCFKSEBM-AVGNSLFASA-N 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- UVZFZTWNHOQWNK-NAKRPEOUSA-N Cys-Ile-Arg Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O UVZFZTWNHOQWNK-NAKRPEOUSA-N 0.000 description 1
- 108010090461 DFG peptide Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 241000672609 Escherichia coli BL21 Species 0.000 description 1
- UWZLBXOBVKRUFE-HGNGGELXSA-N Gln-Ala-His Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCC(=O)N)N UWZLBXOBVKRUFE-HGNGGELXSA-N 0.000 description 1
- YXQCLIVLWCKCRS-RYUDHWBXSA-N Gln-Gly-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)N)O YXQCLIVLWCKCRS-RYUDHWBXSA-N 0.000 description 1
- HPCOBEHVEHWREJ-DCAQKATOSA-N Gln-Lys-Glu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O HPCOBEHVEHWREJ-DCAQKATOSA-N 0.000 description 1
- UWMDGPFFTKDUIY-HJGDQZAQSA-N Gln-Pro-Thr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O UWMDGPFFTKDUIY-HJGDQZAQSA-N 0.000 description 1
- NLKVNZUFDPWPNL-YUMQZZPRSA-N Glu-Arg-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O NLKVNZUFDPWPNL-YUMQZZPRSA-N 0.000 description 1
- ZOXBSICWUDAOHX-GUBZILKMSA-N Glu-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(O)=O ZOXBSICWUDAOHX-GUBZILKMSA-N 0.000 description 1
- SJPMNHCEWPTRBR-BQBZGAKWSA-N Glu-Glu-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O SJPMNHCEWPTRBR-BQBZGAKWSA-N 0.000 description 1
- AUTNXSQEVVHSJK-YVNDNENWSA-N Glu-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O AUTNXSQEVVHSJK-YVNDNENWSA-N 0.000 description 1
- HVYWQYLBVXMXSV-GUBZILKMSA-N Glu-Leu-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O HVYWQYLBVXMXSV-GUBZILKMSA-N 0.000 description 1
- IRXNJYPKBVERCW-DCAQKATOSA-N Glu-Leu-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O IRXNJYPKBVERCW-DCAQKATOSA-N 0.000 description 1
- CUPSDFQZTVVTSK-GUBZILKMSA-N Glu-Lys-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(O)=O CUPSDFQZTVVTSK-GUBZILKMSA-N 0.000 description 1
- ILWHFUZZCFYSKT-AVGNSLFASA-N Glu-Lys-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O ILWHFUZZCFYSKT-AVGNSLFASA-N 0.000 description 1
- ZTVGZOIBLRPQNR-KKUMJFAQSA-N Glu-Met-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZTVGZOIBLRPQNR-KKUMJFAQSA-N 0.000 description 1
- CBOVGULVQSVMPT-CIUDSAMLSA-N Glu-Pro-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O CBOVGULVQSVMPT-CIUDSAMLSA-N 0.000 description 1
- MFYLRRCYBBJYPI-JYJNAYRXSA-N Glu-Tyr-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O MFYLRRCYBBJYPI-JYJNAYRXSA-N 0.000 description 1
- 102000004366 Glucosidases Human genes 0.000 description 1
- 108010056771 Glucosidases Proteins 0.000 description 1
- VXKCPBPQEKKERH-IUCAKERBSA-N Gly-Arg-Pro Chemical compound NC(N)=NCCC[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(O)=O VXKCPBPQEKKERH-IUCAKERBSA-N 0.000 description 1
- KKBWDNZXYLGJEY-UHFFFAOYSA-N Gly-Arg-Pro Natural products NCC(=O)NC(CCNC(=N)N)C(=O)N1CCCC1C(=O)O KKBWDNZXYLGJEY-UHFFFAOYSA-N 0.000 description 1
- XMPXVJIDADUOQB-RCOVLWMOSA-N Gly-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C([O-])=O)NC(=O)CNC(=O)C[NH3+] XMPXVJIDADUOQB-RCOVLWMOSA-N 0.000 description 1
- FSPVILZGHUJOHS-QWRGUYRKSA-N Gly-His-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CNC=N1 FSPVILZGHUJOHS-QWRGUYRKSA-N 0.000 description 1
- UUYBFNKHOCJCHT-VHSXEESVSA-N Gly-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN UUYBFNKHOCJCHT-VHSXEESVSA-N 0.000 description 1
- OJNZVYSGVYLQIN-BQBZGAKWSA-N Gly-Met-Asp Chemical compound [H]NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(O)=O OJNZVYSGVYLQIN-BQBZGAKWSA-N 0.000 description 1
- IGOYNRWLWHWAQO-JTQLQIEISA-N Gly-Phe-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 IGOYNRWLWHWAQO-JTQLQIEISA-N 0.000 description 1
- HFPVRZWORNJRRC-UWVGGRQHSA-N Gly-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN HFPVRZWORNJRRC-UWVGGRQHSA-N 0.000 description 1
- FGPLUIQCSKGLTI-WDSKDSINSA-N Gly-Ser-Glu Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O FGPLUIQCSKGLTI-WDSKDSINSA-N 0.000 description 1
- SFOXOSKVTLDEDM-HOTGVXAUSA-N Gly-Trp-Leu Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CN)=CNC2=C1 SFOXOSKVTLDEDM-HOTGVXAUSA-N 0.000 description 1
- RIYIFUFFFBIOEU-KBPBESRZSA-N Gly-Tyr-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=C(O)C=C1 RIYIFUFFFBIOEU-KBPBESRZSA-N 0.000 description 1
- LMMPTUVWHCFTOT-GARJFASQSA-N His-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC2=CN=CN2)N)C(=O)O LMMPTUVWHCFTOT-GARJFASQSA-N 0.000 description 1
- 108010093488 His-His-His-His-His-His Proteins 0.000 description 1
- VYUXYMRNGALHEA-DLOVCJGASA-N His-Leu-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O VYUXYMRNGALHEA-DLOVCJGASA-N 0.000 description 1
- VFBZWZXKCVBTJR-SRVKXCTJSA-N His-Leu-Asp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N VFBZWZXKCVBTJR-SRVKXCTJSA-N 0.000 description 1
- KHUFDBQXGLEIHC-BZSNNMDCSA-N His-Leu-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CN=CN1 KHUFDBQXGLEIHC-BZSNNMDCSA-N 0.000 description 1
- CYHYBSGMHMHKOA-CIQUZCHMSA-N Ile-Ala-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N CYHYBSGMHMHKOA-CIQUZCHMSA-N 0.000 description 1
- XENGULNPUDGALZ-ZPFDUUQYSA-N Ile-Asn-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)O)N XENGULNPUDGALZ-ZPFDUUQYSA-N 0.000 description 1
- NZOCIWKZUVUNDW-ZKWXMUAHSA-N Ile-Gly-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@@H](C)C(O)=O NZOCIWKZUVUNDW-ZKWXMUAHSA-N 0.000 description 1
- VOBYAKCXGQQFLR-LSJOCFKGSA-N Ile-Gly-Val Chemical compound CC[C@H](C)[C@H](N)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O VOBYAKCXGQQFLR-LSJOCFKGSA-N 0.000 description 1
- FZWVCYCYWCLQDH-NHCYSSNCSA-N Ile-Leu-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)N FZWVCYCYWCLQDH-NHCYSSNCSA-N 0.000 description 1
- ADDYYRVQQZFIMW-MNXVOIDGSA-N Ile-Lys-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N ADDYYRVQQZFIMW-MNXVOIDGSA-N 0.000 description 1
- PARSHQDZROHERM-NHCYSSNCSA-N Ile-Lys-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)O)N PARSHQDZROHERM-NHCYSSNCSA-N 0.000 description 1
- FHPZJWJWTWZKNA-LLLHUVSDSA-N Ile-Phe-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N2CCC[C@@H]2C(=O)O)N FHPZJWJWTWZKNA-LLLHUVSDSA-N 0.000 description 1
- COWHUQXTSYTKQC-RWRJDSDZSA-N Ile-Thr-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N COWHUQXTSYTKQC-RWRJDSDZSA-N 0.000 description 1
- ZGKVPOSSTGHJAF-HJPIBITLSA-N Ile-Tyr-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CO)C(=O)O)N ZGKVPOSSTGHJAF-HJPIBITLSA-N 0.000 description 1
- DBVWMYGBVFCRBE-CIUDSAMLSA-N Leu-Asn-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O DBVWMYGBVFCRBE-CIUDSAMLSA-N 0.000 description 1
- JKGHDYGZRDWHGA-SRVKXCTJSA-N Leu-Asn-Leu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JKGHDYGZRDWHGA-SRVKXCTJSA-N 0.000 description 1
- GBDMISNMNXVTNV-XIRDDKMYSA-N Leu-Asp-Trp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O GBDMISNMNXVTNV-XIRDDKMYSA-N 0.000 description 1
- OYQUOLRTJHWVSQ-SRVKXCTJSA-N Leu-His-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O OYQUOLRTJHWVSQ-SRVKXCTJSA-N 0.000 description 1
- LKXANTUNFMVCNF-IHPCNDPISA-N Leu-His-Trp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O LKXANTUNFMVCNF-IHPCNDPISA-N 0.000 description 1
- QNBVTHNJGCOVFA-AVGNSLFASA-N Leu-Leu-Glu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCC(O)=O QNBVTHNJGCOVFA-AVGNSLFASA-N 0.000 description 1
- QNTJIDXQHWUBKC-BZSNNMDCSA-N Leu-Lys-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O QNTJIDXQHWUBKC-BZSNNMDCSA-N 0.000 description 1
- ONPJGOIVICHWBW-BZSNNMDCSA-N Leu-Lys-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 ONPJGOIVICHWBW-BZSNNMDCSA-N 0.000 description 1
- VULJUQZPSOASBZ-SRVKXCTJSA-N Leu-Pro-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O VULJUQZPSOASBZ-SRVKXCTJSA-N 0.000 description 1
- UCBPDSYUVAAHCD-UWVGGRQHSA-N Leu-Pro-Gly Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O UCBPDSYUVAAHCD-UWVGGRQHSA-N 0.000 description 1
- QONKWXNJRRNTBV-AVGNSLFASA-N Leu-Pro-Met Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)O)N QONKWXNJRRNTBV-AVGNSLFASA-N 0.000 description 1
- YLMIDMSLKLRNHX-HSCHXYMDSA-N Leu-Trp-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O YLMIDMSLKLRNHX-HSCHXYMDSA-N 0.000 description 1
- FBNPMTNBFFAMMH-AVGNSLFASA-N Leu-Val-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N FBNPMTNBFFAMMH-AVGNSLFASA-N 0.000 description 1
- FBNPMTNBFFAMMH-UHFFFAOYSA-N Leu-Val-Arg Natural products CC(C)CC(N)C(=O)NC(C(C)C)C(=O)NC(C(O)=O)CCCN=C(N)N FBNPMTNBFFAMMH-UHFFFAOYSA-N 0.000 description 1
- CGHXMODRYJISSK-NHCYSSNCSA-N Leu-Val-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC(O)=O CGHXMODRYJISSK-NHCYSSNCSA-N 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- WSXTWLJHTLRFLW-SRVKXCTJSA-N Lys-Ala-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O WSXTWLJHTLRFLW-SRVKXCTJSA-N 0.000 description 1
- IRNSXVOWSXSULE-DCAQKATOSA-N Lys-Ala-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN IRNSXVOWSXSULE-DCAQKATOSA-N 0.000 description 1
- GGNOBVSOZPHLCE-GUBZILKMSA-N Lys-Gln-Asp Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O GGNOBVSOZPHLCE-GUBZILKMSA-N 0.000 description 1
- NKKFVJRLCCUJNA-QWRGUYRKSA-N Lys-Gly-Lys Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCCN NKKFVJRLCCUJNA-QWRGUYRKSA-N 0.000 description 1
- SLQJJFAVWSZLBL-BJDJZHNGSA-N Lys-Ile-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCCCN SLQJJFAVWSZLBL-BJDJZHNGSA-N 0.000 description 1
- VMTYLUGCXIEDMV-QWRGUYRKSA-N Lys-Leu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN VMTYLUGCXIEDMV-QWRGUYRKSA-N 0.000 description 1
- LOGFVTREOLYCPF-RHYQMDGZSA-N Lys-Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN LOGFVTREOLYCPF-RHYQMDGZSA-N 0.000 description 1
- YCJCEMKOZOYBEF-OEAJRASXSA-N Lys-Thr-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O YCJCEMKOZOYBEF-OEAJRASXSA-N 0.000 description 1
- QLFAPXUXEBAWEK-NHCYSSNCSA-N Lys-Val-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O QLFAPXUXEBAWEK-NHCYSSNCSA-N 0.000 description 1
- WPTHAGXMYDRPFD-SRVKXCTJSA-N Met-Lys-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O WPTHAGXMYDRPFD-SRVKXCTJSA-N 0.000 description 1
- RMLLCGYYVZKKRT-CIUDSAMLSA-N Met-Ser-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O RMLLCGYYVZKKRT-CIUDSAMLSA-N 0.000 description 1
- PHURAEXVWLDIGT-LPEHRKFASA-N Met-Ser-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N PHURAEXVWLDIGT-LPEHRKFASA-N 0.000 description 1
- SQPZCTBSLIIMBL-BPUTZDHNSA-N Met-Trp-Ser Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CO)C(=O)O)N SQPZCTBSLIIMBL-BPUTZDHNSA-N 0.000 description 1
- WUGMRIBZSVSJNP-UHFFFAOYSA-N N-L-alanyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C)C(O)=O)=CNC2=C1 WUGMRIBZSVSJNP-UHFFFAOYSA-N 0.000 description 1
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 1
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 1
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 1
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 1
- 108010079364 N-glycylalanine Proteins 0.000 description 1
- ULECEJGNDHWSKD-QEJZJMRPSA-N Phe-Ala-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 ULECEJGNDHWSKD-QEJZJMRPSA-N 0.000 description 1
- MECSIDWUTYRHRJ-KKUMJFAQSA-N Phe-Asn-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O MECSIDWUTYRHRJ-KKUMJFAQSA-N 0.000 description 1
- FRPVPGRXUKFEQE-YDHLFZDLSA-N Phe-Asp-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O FRPVPGRXUKFEQE-YDHLFZDLSA-N 0.000 description 1
- XXAOSEUPEMQJOF-KKUMJFAQSA-N Phe-Glu-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 XXAOSEUPEMQJOF-KKUMJFAQSA-N 0.000 description 1
- OVJMCXAPGFDGMG-HKUYNNGSSA-N Phe-Gly-Trp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O OVJMCXAPGFDGMG-HKUYNNGSSA-N 0.000 description 1
- ZJPGOXWRFNKIQL-JYJNAYRXSA-N Phe-Pro-Pro Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=CC=C1 ZJPGOXWRFNKIQL-JYJNAYRXSA-N 0.000 description 1
- JARJPEMLQAWNBR-GUBZILKMSA-N Pro-Asp-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O JARJPEMLQAWNBR-GUBZILKMSA-N 0.000 description 1
- NMELOOXSGDRBRU-YUMQZZPRSA-N Pro-Glu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H]1CCCN1 NMELOOXSGDRBRU-YUMQZZPRSA-N 0.000 description 1
- FMLRRBDLBJLJIK-DCAQKATOSA-N Pro-Leu-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1 FMLRRBDLBJLJIK-DCAQKATOSA-N 0.000 description 1
- MCWHYUWXVNRXFV-RWMBFGLXSA-N Pro-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 MCWHYUWXVNRXFV-RWMBFGLXSA-N 0.000 description 1
- INDVYIOKMXFQFM-SRVKXCTJSA-N Pro-Lys-Gln Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)O INDVYIOKMXFQFM-SRVKXCTJSA-N 0.000 description 1
- GZFAWAQTEYDKII-YUMQZZPRSA-N Ser-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO GZFAWAQTEYDKII-YUMQZZPRSA-N 0.000 description 1
- JFWDJFULOLKQFY-QWRGUYRKSA-N Ser-Gly-Phe Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JFWDJFULOLKQFY-QWRGUYRKSA-N 0.000 description 1
- CICQXRWZNVXFCU-SRVKXCTJSA-N Ser-His-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O CICQXRWZNVXFCU-SRVKXCTJSA-N 0.000 description 1
- MUJQWSAWLLRJCE-KATARQTJSA-N Ser-Leu-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MUJQWSAWLLRJCE-KATARQTJSA-N 0.000 description 1
- BUYHXYIUQUBEQP-AVGNSLFASA-N Ser-Phe-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CO)N BUYHXYIUQUBEQP-AVGNSLFASA-N 0.000 description 1
- UKKROEYWYIHWBD-ZKWXMUAHSA-N Ser-Val-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O UKKROEYWYIHWBD-ZKWXMUAHSA-N 0.000 description 1
- JZRYFUGREMECBH-XPUUQOCRSA-N Ser-Val-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O JZRYFUGREMECBH-XPUUQOCRSA-N 0.000 description 1
- AHOLTQCAVBSUDP-PPCPHDFISA-N Thr-Ile-Lys Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](N)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O AHOLTQCAVBSUDP-PPCPHDFISA-N 0.000 description 1
- PCMDGXKXVMBIFP-VEVYYDQMSA-N Thr-Met-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(O)=O PCMDGXKXVMBIFP-VEVYYDQMSA-N 0.000 description 1
- QAXCHNZDPLSFPC-PJODQICGSA-N Trp-Ala-Arg Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)=CNC2=C1 QAXCHNZDPLSFPC-PJODQICGSA-N 0.000 description 1
- OTWIOROMZLNAQC-XIRDDKMYSA-N Trp-His-Asp Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(O)=O OTWIOROMZLNAQC-XIRDDKMYSA-N 0.000 description 1
- VNRTXOUAOUZCFW-WDSOQIARSA-N Trp-Val-His Chemical compound CC(C)[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O VNRTXOUAOUZCFW-WDSOQIARSA-N 0.000 description 1
- GFZQWWDXJVGEMW-ULQDDVLXSA-N Tyr-Arg-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)O)N)O GFZQWWDXJVGEMW-ULQDDVLXSA-N 0.000 description 1
- CRWOSTCODDFEKZ-HRCADAONSA-N Tyr-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)C(=O)O CRWOSTCODDFEKZ-HRCADAONSA-N 0.000 description 1
- DKKHULUSOSWGHS-UWJYBYFXSA-N Tyr-Asn-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)N DKKHULUSOSWGHS-UWJYBYFXSA-N 0.000 description 1
- GAYLGYUVTDMLKC-UWJYBYFXSA-N Tyr-Asp-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 GAYLGYUVTDMLKC-UWJYBYFXSA-N 0.000 description 1
- NOOMDULIORCDNF-IRXDYDNUSA-N Tyr-Gly-Phe Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O NOOMDULIORCDNF-IRXDYDNUSA-N 0.000 description 1
- SFSZDJHNAICYSD-PMVMPFDFSA-N Tyr-His-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC3=CN=CN3)NC(=O)[C@H](CC4=CC=C(C=C4)O)N SFSZDJHNAICYSD-PMVMPFDFSA-N 0.000 description 1
- QFXVAFIHVWXXBJ-AVGNSLFASA-N Tyr-Ser-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O QFXVAFIHVWXXBJ-AVGNSLFASA-N 0.000 description 1
- PLVVHGFEMSDRET-IHPCNDPISA-N Tyr-Ser-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CC=C(C=C3)O)N PLVVHGFEMSDRET-IHPCNDPISA-N 0.000 description 1
- LVILBTSHPTWDGE-PMVMPFDFSA-N Tyr-Trp-Lys Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCCN)C(O)=O)C1=CC=C(O)C=C1 LVILBTSHPTWDGE-PMVMPFDFSA-N 0.000 description 1
- AGDDLOQMXUQPDY-BZSNNMDCSA-N Tyr-Tyr-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(O)=O AGDDLOQMXUQPDY-BZSNNMDCSA-N 0.000 description 1
- COYSIHFOCOMGCF-UHFFFAOYSA-N Val-Arg-Gly Natural products CC(C)C(N)C(=O)NC(C(=O)NCC(O)=O)CCCN=C(N)N COYSIHFOCOMGCF-UHFFFAOYSA-N 0.000 description 1
- OQWNEUXPKHIEJO-NRPADANISA-N Val-Glu-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)N OQWNEUXPKHIEJO-NRPADANISA-N 0.000 description 1
- BZWUSZGQOILYEU-STECZYCISA-N Val-Ile-Tyr Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 BZWUSZGQOILYEU-STECZYCISA-N 0.000 description 1
- RYQUMYBMOJYYDK-NHCYSSNCSA-N Val-Pro-Glu Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)O)C(=O)O)N RYQUMYBMOJYYDK-NHCYSSNCSA-N 0.000 description 1
- UGFMVXRXULGLNO-XPUUQOCRSA-N Val-Ser-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O UGFMVXRXULGLNO-XPUUQOCRSA-N 0.000 description 1
- WUFHZIRMAZZWRS-OSUNSFLBSA-N Val-Thr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C(C)C)N WUFHZIRMAZZWRS-OSUNSFLBSA-N 0.000 description 1
- MIAZWUMFUURQNP-YDHLFZDLSA-N Val-Tyr-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N MIAZWUMFUURQNP-YDHLFZDLSA-N 0.000 description 1
- GUIYPEKUEMQBIK-JSGCOSHPSA-N Val-Tyr-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NCC(O)=O GUIYPEKUEMQBIK-JSGCOSHPSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 108010086434 alanyl-seryl-glycine Proteins 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 108010070944 alanylhistidine Proteins 0.000 description 1
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 1
- 108010062796 arginyllysine Proteins 0.000 description 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
- 108010093581 aspartyl-proline Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000008358 core component Substances 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 108010078144 glutaminyl-glycine Proteins 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 1
- 108010045126 glycyl-tyrosyl-glycine Proteins 0.000 description 1
- 108010015792 glycyllysine Proteins 0.000 description 1
- 108010087823 glycyltyrosine Proteins 0.000 description 1
- 108010037850 glycylvaline Proteins 0.000 description 1
- 206010073071 hepatocellular carcinoma Diseases 0.000 description 1
- 231100000844 hepatocellular carcinoma Toxicity 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 229940042040 innovative drug Drugs 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 108010034529 leucyl-lysine Proteins 0.000 description 1
- 108010047926 leucyl-lysyl-tyrosine Proteins 0.000 description 1
- 108010003700 lysyl aspartic acid Proteins 0.000 description 1
- 108010038320 lysylphenylalanine Proteins 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 108010005942 methionylglycine Proteins 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 108700042769 prolyl-leucyl-glycine Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000011272 standard treatment Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 108010029384 tryptophyl-histidine Proteins 0.000 description 1
- 108010084932 tryptophyl-proline Proteins 0.000 description 1
- 108010051110 tyrosyl-lysine Proteins 0.000 description 1
- 108010020532 tyrosyl-proline Proteins 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 108010073969 valyllysine Proteins 0.000 description 1
- 239000007222 ypd medium Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
本发明公开了一种重组大肠杆菌KLUGIN73及其应用,其保藏编号为:CCTCC NO:M 2022248;本发明的大肠杆菌KLUGIN73所产生的嗜热糖苷酶兼有水解葡萄糖苷和鼠李糖苷的能力,底物谱广,能实现淫羊藿苷的二糖基一次性水解,反应条件简单且单一,大幅降低酶法水解淫羊藿苷的成本;本发明涉及的水解淫羊藿苷工艺,目标产物单一,即淫羊藿素,没有副产物产生,产品的得率接近100%;本发明的重组糖苷酶可在纯水相中完全水解10mM的淫羊藿苷,其浓度远超其在水中溶解度的1000倍以上,使得酶法水解淫羊藿苷生产淫羊藿素工艺更具有工业化应用价值。
Description
技术领域
本发明涉及生物发酵领域,具体涉及一种重组大肠杆菌KLUGIN73 及其应用。
背景技术
2022年1月10日,国家药品监督管理局批准淫羊藿素(阿可拉定)软胶囊为国家一类创新药,获批用于不适合或患者拒绝接受标准治疗,且既往未接受过全身系统性治疗的、不可切除的肝细胞癌。其核心成分淫羊藿素 (Icaritin,别名:3,5,7-三羟基-2-(4-甲氧苯基)-8-(3-甲基-2-丁烯-1-基) -4H-1-苯并吡喃-4-酮,CAS号:118525-40-9)来源于传统草本中药—淫羊藿。
然而草本植物淫羊藿中,淫羊藿素几乎不存在,它通常以结合一分子葡萄糖和一分子鼠李糖的二糖苷形式存在。该糖苷被称为淫羊藿苷 (Icariin,别名:4′-O-甲基-8-γ,γ-dimethylallylkaempferol-3-鼠李糖苷素-7- 葡糖苷,CAS号489-32-7),属于8-异戊烯基黄酮苷类化合物,在淫羊藿草本中含量低于0.1%。因此必须将淫羊藿苷上两分子糖基水解后才能发挥药效。但是哺乳动物细胞自身无法生产糖苷酶,只能依靠肠道中某些微生物产生的糖苷酶将糖苷水解而获取苷元,因此肠道微生物糖苷酶的活性决定了人体吸收中药有效成分的能力,这也就是中药“因人而异”的原因之一。
化学法利用强酸水解淫羊藿苷生产淫羊藿素,但由于酸水解效率不高,而且通常会导致烯烃键上的甲基和酚羟基脱水成环而不可避免地产生大量副产物-脱水淫羊藿素(CAS号38226-86-7),导致产率低,生产成本高,且过量使用强酸对环境的压力大。
目前有报道用特殊葡萄糖苷酶和鼠李糖苷酶复配后,在常温,中强酸条件下水解淫羊藿苷生产淫羊藿素。该方法具有对环境友好,而且无副产物产生等诸多优点。但是其以下缺点也不容忽视:
1.由于酶对底物的特异性,目前只有生产两种催化剂(酶)才能获得淫羊藿素,因此催化剂的生产成本被提高。另外,两种酶水解条件的差异性,导致水解反应效率的下降;
2.底物淫羊藿苷的水溶性极低(溶于乙醇、乙酸乙酯,难溶于水,不溶于醚、苯、氯仿),即使在甲醇中溶解度也不超过3mM。而常规的酶制剂只能在水相中,且无法耐受高浓度的有机溶剂。因此酶水解的工作浓度很低,最终导致水解体积过大,加大后续纯化工作的压力;
3.高温会导致酶失活,因此通常酶的工作温度为25-40℃。但是这样的温度过低,不利于底物在水相中溶解,变相降低了酶促反应速度,最终到账时空产率低;
4.目前报道酶法生产淫羊藿素的生产周期为48-96小时,反应周期长,酶容易失活,时空产率不高,最终导致生产成本上升。
基于酶法水解淫羊藿苷生产淫羊藿素的优缺点,我们必要进一步寻找一种高效的、耐底物浓度高、热稳定性强且底物谱广的糖苷酶,以满足大规模工业生产淫羊藿素的需要。
发明内容
本发明针对目前酶法水解淫羊藿苷生产淫羊藿素存在底物耐受低,时空产率不高,工业化应用成本高的问题,提供了一株重组大肠杆菌 KLUGIN73,该菌表达一种嗜热糖苷酶,在高温下快速水解淫羊藿苷生产淫羊藿素,有效提升了酶解反应的时空产率。本发明的重组大肠杆菌 KLUGIN73生产的嗜热酶,底物谱广,耐高底物浓度,对葡萄糖基和鼠李糖基都实现快速切除,且高温下热稳定性极好,降低酶解反应过程中酶活下降的风险,大幅降低催化剂的使用成本。
为实现上述目的,本发明所设计一株重组大肠杆菌KLUGIN73,所述重组大肠杆菌KLUGIN73,其保藏编号为:CCTCC NO:M 2022248。
上述重组菌命名为大肠杆菌KLUGIN73,命名为:Escherichia coli KLUGIN73;并于2022年3月11日保藏于中国典型培养物保藏中心,湖北省武汉市武昌珞珈山武汉大学,其保藏编号为CCTCC NO:M 2022248。
进一步地,所述重组大肠杆菌KLUGIN73中含有blg-XT1412基因, blg-XT1412基因的核苷酸序列如SEQ ID No.1。
再进一步地,所述大肠杆菌为BL21。
本发明还提供了一种上述的重组大肠杆菌KLUGIN73在制备嗜热糖苷酶中的应用。
本发明还提供了一种上述的重组大肠杆菌KLUGIN73在发酵工艺中的应用。
本发明还提供了一种上述的重组大肠杆菌KLUGIN73生产糖苷酶的方法,包括以下步骤:
1)将重组大肠杆菌KLUGIN73活化,
2)将活化的重组大肠杆菌KLUGIN73置于发酵培养基中发酵,得到发酵产物;
3)将发酵产物中IPTG诱导产酶处理,得到含有重组蛋白XT1412 的大肠杆菌KLUGIN73。
进一步地,所述步骤2)中,
发酵培养基配方为:
碳源:甘油1-3%;氮源:酵母浸粉0.2-1.5%,胰蛋白胨1-3%;无机盐:磷酸二氢钾0.1-0.4%,磷酸氢二钾0.1-0.3%,硫酸铵0.05-0.2%;pH: 6-8;
发酵条件:接种量为:0.1-2%(体积比);培养时间:12-24小时;培养温度:25-40℃;搅拌速度:100-250r/min。
所述步骤3)中,产酶条件:IPTG(异丙基-β-D-硫代半乳糖苷)的终浓度0.05mM;培养时间:4-12小时;培养温度:15-35℃;搅拌速度: 50-200r/min。
本发明还提供了一种上述的重组大肠杆菌KLUGIN73在水解生产淫羊藿素工艺中的应用。
进一步地,所述应用中,
反应温度为60℃~100℃,反应pH值为5.0~7.5,反应淫羊藿苷底物浓度为5~12mM;
淫羊藿苷和重组大肠杆菌KLUGIN73发酵液投料比为0.5~5g/L;
水解时间为2.5~5小时。
再进一步地,所述应用中,
反应温度为80℃~100℃,最优选为95℃
反应pH值为5.5~7,最优选为6.5
反应淫羊藿苷底物浓度为8~10mM;最优选为10mM
淫羊藿苷和重组大肠杆菌KLUGIN73发酵液投料比为1~3g/L;最优选为2g/L
水解时间为3~4小时,最优选为3小时。
本发明的有益效果:
1)本发明的大肠杆菌KLUGIN73所产生的嗜热糖苷酶兼有水解葡萄糖苷和鼠李糖苷的能力,底物谱广,能实现淫羊藿苷(葡萄糖、鼠李糖二糖苷)的二糖基一次性水解,反应条件简单且单一,大幅降低酶法水解淫羊藿苷的成本;
2)本发明的重组糖苷酶最适反应温度为95℃,该温度下底物淫羊藿苷溶解度相较于常温下更高,有利于水解反应发生,反应速率相较于常温酶提高15-30倍;
3)本发明涉及的水解淫羊藿苷工艺,目标产物单一,即淫羊藿素,没有副产物产生(酸水解法会产生大量副产物—脱水淫羊藿素),产品的得率接近100%,如图1所示;
4)本发明的重组糖苷酶可在纯水相中完全水解10mM的淫羊藿苷,其浓度远超其在水中溶解度的1000倍以上,使得酶法水解淫羊藿苷生产淫羊藿素工艺更具有工业化应用价值;
5)本发明涉及的水解淫羊藿苷工艺,在纯水相中进行,无需添加有机溶剂、无机强酸和盐,对环境友好;
6)本发明可实现淫羊藿素(阿可拉定)≥1.28g/L/h的时空产率。
附图说明
图1为重组大肠杆菌KLUGIN73水解淫羊藿苷的HPLC-MS图;
图2为pET24a-blg-XT1412环状质粒图;
图3为水解温度优化图;
图4为水解pH优化图;
图5为最佳底物浓度优化图;
图6为投料比优化图;
图7为最佳水解反应时间时间优化图。
具体实施方式
下面结合具体实施例对本发明作进一步的详细描述,以便本领域技术人员理解。
实施例1重组大肠杆菌KLUGIN73的构建
1.blg-XT1412酶基因的克隆
1.1引物设计
根据blg-XT1412基因序列利用GeneFisher软件在线设计简并引物:
上游引物:5'-ttaGCGGCCGCATGTCCCCCATCCTC-3';
下游引物:5'-ggcGAATTCTTAGTGATGGTGATG-3'。
1.2模板制备
用100ml的液体YPD培养基,活化乳酸克鲁维酵母(Kluyveromyces lactis)XT1412(乳酸克鲁维酵母(Kluyveromyces lactis)XT1412公开于公开号为CN10812936A,发明名称为“乳酸克鲁维酵母突变株及其糖苷酶和应用”的中国发明专利),28℃,250rpm连续培养2天。培养结束后5000rpm离心10min,收集菌体抽提基因组DNA,产物于-20℃保藏待用。
1.3基因扩增
以步骤1.2中产物为模板,用实施例1.1中设计的简并引物和DNA 聚合酶进行PCR,具体反应条件如下:
反应结束后进行琼脂糖凝胶电泳确认基因大小,并将出现1500-1600 bp片段,用甘油管于-20℃保藏。
2.构建pET24a-bgl-XT1412环状质粒
上述步骤1.3中回收基因片段测序结果正确后,利用Not I和EcoR I 对PCR产物进行双酶切。酶切反应结束后进行琼脂糖凝胶电泳分离,将 1512bp的片段分别切胶回收,于-20℃保藏。
利用Not I和EcoR I对pET24a载体进行双酶切。酶切反应结束后进行琼脂糖凝胶电泳分离,将5284bp的片段切胶回收,于-20℃保藏。
在10μl体系中,加入0.5μl线性化pET24a载体,5μl经双酶切的 PCR产物,1μl 10×buffer,1μl T4连接酶,2.5μl无菌ddH2O。于16℃连接过夜。
连接反应结束后,转化到大肠杆菌DH5α。鉴定为阳性克隆后,抽提质粒,得到pET24a-bgl-XT1412环状质粒,于-20℃载体保藏,该环状质粒图谱如图2所示。
3.重组大肠杆菌KLUGIN73的构建
3.1电转化
将置于冰上的大肠杆菌BL21感受态细胞,加入2中保藏的 pET24a-bgl-XT1412环状质粒,混合均匀进行电击转化。转化结束后将电转化杯中的所有液体转移到无菌Eppendorf管,30℃水浴,2h,10000rpm 离心l min,弃上清,菌体用无菌水悬浮后涂布于含有50μg/ml卡那霉素的LB琼脂培养基平板上,37℃静置培养1天出现克隆。
3.2重组子基因鉴定
从实施例3.1中随机挑取克隆子,接入含有50μg/ml卡那霉素的LB 液体培养基中37℃,250rpm培养12小时。培养结束后5000rpm离心 10min,收集菌体。使用与1.3中相同引物和条件与DNA聚合酶进行PCR 反应。
反应结束后进行琼脂糖凝胶电泳确认基因大小。出现1512bp片段的克隆子为阳性,将该克隆子用甘油管于-20℃保藏。
3.3糖苷酶的酶活鉴定
将实施例3.2中重组子发酵后收集菌体,用磷酸钠缓冲液悬浮,以邻硝基苯酚β-D葡萄糖苷(pNPG)为底物进行测定。测活的体系为:磷酸钠缓冲液0.05ml(100mM,pH 7.0)+0.05ml待测菌溶液+15μl pNPG(100 mM,溶于DMSO中),以不加酶液为空白对照,反应温度为95℃,反应时间1min。加入0.1ml浓度为1M Na2CO3终止反应;用酶标仪,在405 nm下取吸光度值(OD)。
3.4重组子鉴定和保藏
将实施例3.2阳性克隆子接种到液体含有50ug/ml卡那霉素液体培养基中,37℃,250rpm培养12小时。当OD600值大于0.4,加入IPTG (异丙基-β-D-硫代半乳糖苷)使其终浓度为0.05mM,30℃,150rpm 诱导4小时离心收集菌体。利用实施例3.3中所述方法测定酶活,将一株酶活阳性的菌株接入无菌甘油管,于-20℃保藏,得到重组菌命名为大肠杆菌KLUGIN73,命名为:Escherichia coli KLUGIN73;并于2022年3 月11日保藏于中国典型培养物保藏中心,湖北省武汉市武昌珞珈山武汉大学,其保藏编号为CCTCC NO:M 2022248。
实施例2重组大肠杆菌KLUGIN73的生产发酵工艺
2.1发酵培养基的确定发酵培养基由碳源,氮源和无机盐组成,适用于5-10000L发酵罐,具体成分如下:
碳源:甘油1-3%;
氮源:酵母浸粉0.2-1.5%,胰蛋白胨1-3%;无机盐:磷酸二氢钾 0.1-0.4%,磷酸氢二钾0.1-0.3%,硫酸铵0.05-0.2%,pH:6-8(氨水调节)。
2.2发酵培养和诱导产酶条件的确定
发酵培养基如2.1所示,发酵培养条件具体如下:
接种量:0.1-2%(体积比);
培养时间:12-24小时;
培养温度:25-40℃
搅拌速度:100-250r/min
培养结束后,加入IPTG(异丙基-β-D-硫代半乳糖苷)使其终浓度为0.05mM,开启产酶发酵,培养条件具体如下:
培养时间:4-12小时
培养温度:15-35℃
搅拌速度:50-200r/min
培养结束后(发酵液OD600=35-50),根据实施例3.3所示方法确定酶活力。离心,收集菌体于4℃保藏待用。
上述方案适用于5L-10000L发酵罐。
实施例3重组大肠杆菌KLUGIN73生产糖苷酶的方法
1)将重组大肠杆菌KLUGIN73活化,
2)将活化的重组大肠杆菌KLUGIN73置于发酵培养基中发酵,得到发酵产物;其中,发酵培养基配方为:
碳源:甘油1-3%;氮源:酵母浸粉0.2-1.5%,胰蛋白胨1-3%;无机盐:磷酸二氢钾0.1-0.4%,磷酸氢二钾0.1-0.3%,硫酸铵0.05-0.2%;pH: 6-8(氨水调节);
发酵条件:接种量:0.1-2%(体积比);培养时间:12-24小时;培养温度:25-40℃;搅拌速度:100-250r/min;
3)将发酵产物诱导产酶处理,得到含有重组蛋白XT1412的大肠杆菌KLUGIN73;其中,
产酶条件:向发酵产物中加入IPTG(异丙基-β-D-硫代半乳糖苷)使其终浓0.05mM;培养时间:4-12小时;培养温度:15-35℃;搅拌速度: 50-200r/min。
实施例4重组大肠杆菌KLUGIN73水解淫羊藿苷生产淫羊藿素工艺
4.1水解温度优化
取实施例2的2.2中,重组大肠杆菌KLUGIN73,在pH 6.0的50mM 磷酸盐缓冲液中,加入5mM淫羊藿苷,分别在30-100℃下连续反应10 分钟,利用HPLC-MS检测淫羊藿苷的转化率,确定最佳反应温度;
结果如图3所示:反应温度为30℃~100℃,优选为60℃~100℃,更优选为80℃~100℃,最优选为95℃。
4.2水解温度优化
取实施例2的2.2中,重组大肠杆菌KLUGIN73,分别在pH4.5-8.0 的50mM磷酸盐缓冲液中,加入5mM淫羊藿苷,在95℃下连续反应 10分钟,利用HPLC-MS检测淫羊藿苷的转化率,确定最佳反应pH;
结果如图4所示:反应pH值为4.5~8,优选为5.0~7.5,更优选为5.5~7,最优选为6.5。
4.3淫羊藿苷浓度优化
取实施例2的2.2中,重组大肠杆菌KLUGIN73,在pH 6.5的50mM 磷酸盐缓冲液中,加入0.5~20mM淫羊藿苷,在95℃下连续反应10分钟,利用HPLC-MS检测淫羊藿苷的含量,确定最佳水解速率;
结果如图5所示:淫羊藿苷底物浓度0.5~20mM,优选为5~12mM,更优选为8~10mM,最优选为10mM。
4.4投料比优化(淫羊藿苷(g):重组大肠杆菌KLUGIN73发酵体积(L))
取实施例2的2.2中,重组大肠杆菌KLUGIN73,投料比分别为0.1~10 g/L,在pH6.5的50mM磷酸盐缓冲液中,95℃下连续反应10分钟,利用HPLC-MS检测淫羊藿素的产率确定最佳投料比;
结果如图6所示:投料比0.1~10g/L,优选为0.5~5g/L,更优选为1~3 g/L,最优选为2g/L。
4.5水解时间优化
取实施例2的2.2中,重组大肠杆菌KLUGIN73,投料比分别为2g/L,在pH 6.5的50mM磷酸盐缓冲液中,95℃下连续反应10分钟,利用 HPLC-MS检测淫羊藿素的产率确定最佳水解时间;
结果如图7所示:反应时间0.5~8小时,优选为2.5~5小时,更优选为3~4小时,最优选为3小时。
其它未详细说明的部分均为现有技术。尽管上述实施例对本发明做出了详尽的描述,但它仅仅是本发明一部分实施例,而不是全部实施例,人们还可以根据本实施例在不经创造性前提下获得其他实施例,这些实施例都属于本发明保护范围。
序列表
<110> 董颖军
<120> 重组大肠杆菌KLUGIN73及其应用
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 1512
<212> DNA
<213> 乳酸克鲁维酵母(Kluyveromyces lactis)
<400> 1
atgtccccca tcctcggtta ctggaagatc aagggtctcg tccgcttccc caagcagggt 60
cccctcggtt tcggttactc ctggtccggt ttccagttcg agatgggtct gcccggttcc 120
gaggtcgagt ccgactggtg ggtctgggtc cacgacaagg agaacatcgc ctccggtctg 180
gtctccggtg acctgcccga gaacggtccc gcctactggc acctgtacaa gcaggaccac 240
gacatcgccg agaagctggg tatggactgc atccgcggtg gtatcgagtg ggcccgcatc 300
ttccccaagc ccaccttcga cgtcaaggtc gacgtcgaga aggacgagga gggtaacatc 360
atctccgtcg acgtccccga gtccaccatc aaggagctgg agaagatcgc caacatggag 420
gccctggagc actaccgcaa gatctactcc gactggaagg agcgcggtaa gaccttcatc 480
ctgaacctgt accactggcc cctgcccctg tggatccacg accccatcgc cgtccgcaag 540
ctgggtcccg accgcgcccc cgccggttgg ctggacgaga agaccgtcgt cgagttcgtc 600
aagttcgccg ccttcgtcgc ctaccacctg gacgacctgg tcgacatgtg gtccaccatg 660
aacgagccca acgtcgtcta caaccagggt tacatcaacc tgcgctccgg tttccccccc 720
ggttacctgt ccttcgaggc cgccgagaag gccaagttca acctgatcca ggcccacatc 780
ggtgcctacg acgccatcaa ggagtactcc gagaagtccg tcggtgtcat ctacgccttc 840
gcctggcacg accccctggc cgaggagtac aaggacgagg tcgaggagat ccgcaagaag 900
gactacgagt tcgtcaccat cctgcactcc aagggtaagc tggactggat cggtgtcaac 960
tactactccc gcctggtcta cggtgccaag gacggtcacc tggtccccct gcccggttac 1020
ggtttcatgt ccgagcgcgg tggtttcgcc aagtccggtc gccccgcctc cgacttcggt 1080
tgggagatgt accccgaggg tctggagaac ctgctgaagt acctgaacaa cgcctacgag 1140
ctgcccatga tcatcaccga gaacggtatg gccgacgccg ccgaccgcta ccgcccccac 1200
tacctggtct cccacctgaa ggccgtctac aacgccatga aggagggtgc cgacgtccgc 1260
ggttacctgc actggtccct gaccgacaac tacgagtggg cccagggttt ccgcatgcgc 1320
ttcggtctgg tctacgtcga cttcgagacc aagaagcgct acctgcgccc ctccgccctg 1380
gtcttccgcg agatcgccac ccagaaggag atccccgagg agctggccca cctggccgac 1440
ctgaagttcc agcccacccg cctcctcctc gagtacctcg tcaccaagcg ccatcaccat 1500
caccatcact aa 1512
<210> 2
<211> 503
<212> PRT
<213> 乳酸克鲁维酵母(Kluyveromyces lactis)
<400> 2
Met Ser Pro Ile Leu Gly Tyr Trp Lys Ile Lys Gly Leu Val Arg Phe
1 5 10 15
Pro Lys Gln Gly Pro Leu Gly Phe Gly Tyr Ser Trp Ser Gly Phe Gln
20 25 30
Phe Glu Met Gly Leu Pro Gly Ser Glu Val Glu Ser Asp Trp Trp Val
35 40 45
Trp Val His Asp Lys Glu Asn Ile Ala Ser Gly Leu Val Ser Gly Asp
50 55 60
Leu Pro Glu Asn Gly Pro Ala Tyr Trp His Leu Tyr Lys Gln Asp His
65 70 75 80
Asp Ile Ala Glu Lys Leu Gly Met Asp Cys Ile Arg Gly Gly Ile Glu
85 90 95
Trp Ala Arg Ile Phe Pro Lys Pro Thr Phe Asp Val Lys Val Asp Val
100 105 110
Glu Lys Asp Glu Glu Gly Asn Ile Ile Ser Val Asp Val Pro Glu Ser
115 120 125
Thr Ile Lys Glu Leu Glu Lys Ile Ala Asn Met Glu Ala Leu Glu His
130 135 140
Tyr Arg Lys Ile Tyr Ser Asp Trp Lys Glu Arg Gly Lys Thr Phe Ile
145 150 155 160
Leu Asn Leu Tyr His Trp Pro Leu Pro Leu Trp Ile His Asp Pro Ile
165 170 175
Ala Val Arg Lys Leu Gly Pro Asp Arg Ala Pro Ala Gly Trp Leu Asp
180 185 190
Glu Lys Thr Val Val Glu Phe Val Lys Phe Ala Ala Phe Val Ala Tyr
195 200 205
His Leu Asp Asp Leu Val Asp Met Trp Ser Thr Met Asn Glu Pro Asn
210 215 220
Val Val Tyr Asn Gln Gly Tyr Ile Asn Leu Arg Ser Gly Phe Pro Pro
225 230 235 240
Gly Tyr Leu Ser Phe Glu Ala Ala Glu Lys Ala Lys Phe Asn Leu Ile
245 250 255
Gln Ala His Ile Gly Ala Tyr Asp Ala Ile Lys Glu Tyr Ser Glu Lys
260 265 270
Ser Val Gly Val Ile Tyr Ala Phe Ala Trp His Asp Pro Leu Ala Glu
275 280 285
Glu Tyr Lys Asp Glu Val Glu Glu Ile Arg Lys Lys Asp Tyr Glu Phe
290 295 300
Val Thr Ile Leu His Ser Lys Gly Lys Leu Asp Trp Ile Gly Val Asn
305 310 315 320
Tyr Tyr Ser Arg Leu Val Tyr Gly Ala Lys Asp Gly His Leu Val Pro
325 330 335
Leu Pro Gly Tyr Gly Phe Met Ser Glu Arg Gly Gly Phe Ala Lys Ser
340 345 350
Gly Arg Pro Ala Ser Asp Phe Gly Trp Glu Met Tyr Pro Glu Gly Leu
355 360 365
Glu Asn Leu Leu Lys Tyr Leu Asn Asn Ala Tyr Glu Leu Pro Met Ile
370 375 380
Ile Thr Glu Asn Gly Met Ala Asp Ala Ala Asp Arg Tyr Arg Pro His
385 390 395 400
Tyr Leu Val Ser His Leu Lys Ala Val Tyr Asn Ala Met Lys Glu Gly
405 410 415
Ala Asp Val Arg Gly Tyr Leu His Trp Ser Leu Thr Asp Asn Tyr Glu
420 425 430
Trp Ala Gln Gly Phe Arg Met Arg Phe Gly Leu Val Tyr Val Asp Phe
435 440 445
Glu Thr Lys Lys Arg Tyr Leu Arg Pro Ser Ala Leu Val Phe Arg Glu
450 455 460
Ile Ala Thr Gln Lys Glu Ile Pro Glu Glu Leu Ala His Leu Ala Asp
465 470 475 480
Leu Lys Phe Gln Pro Thr Arg Leu Leu Leu Glu Tyr Leu Val Thr Lys
485 490 495
Arg His His His His His His
500
Claims (10)
1.一株重组大肠杆菌KLUGIN73,其特征在于:所述重组大肠杆菌KLUGIN73,其保藏编号为:CCTCC NO:M 2022248。
上述重组菌命名为大肠杆菌KLUGIN73,命名为:Escherichia coli KLUGIN73;并于2022年3月11日保藏于中国典型培养物保藏中心,湖北省武汉市武昌珞珈山武汉大学,其保藏编号为CCTCC NO:M 2022248。
2.根据权利要求1所述的重组大肠杆菌KLUGIN73,其特征在于:所述重组大肠杆菌KLUGIN73中含有blg-XT1412基因,blg-XT1412基因的核苷酸序列如SEQ ID No.1。
3.根据权利要求1所述的重组大肠杆菌KLUGIN73,其特征在于:所述大肠杆菌为BL21。
4.一种权利要求1所述的重组大肠杆菌KLUGIN73在制备嗜热糖苷酶中的应用。
5.一种权利要求1所述的重组大肠杆菌KLUGIN73在发酵工艺中的应用。
6.一种权利要求1所述的重组大肠杆菌KLUGIN73生产糖苷酶的方法,其特征在于:包括以下步骤:
1)将重组大肠杆菌KLUGIN73活化,
2)将活化的重组大肠杆菌KLUGIN73置于发酵培养基中发酵,得到发酵产物;
3)将发酵产物中IPTG诱导产酶处理,得到含有重组蛋白XT1412的大肠杆菌KLUGIN73。
7.根据权利要求6所述的方法,其特征在于:所述步骤2)中,
发酵培养基配方为:
碳源:甘油1-3%;氮源:酵母浸粉0.2-1.5%,胰蛋白胨1-3%;无机盐:磷酸二氢钾0.1-0.4%,磷酸氢二钾0.1-0.3%,硫酸铵0.05-0.2%;pH:6-8;
发酵条件:接种量为:0.1-2%;培养时间:12-24小时;培养温度:25-40℃;搅拌速度:100-250r/min。
所述步骤3)中,产酶条件:IPTG的终浓度0.05mM;培养时间:4-12小时;培养温度:15-35℃;搅拌速度:50-200r/min。
8.一种权利要求1所述的重组大肠杆菌KLUGIN73在水解生产淫羊藿素工艺中的应用。
9.根据权利要求8所述的应用,其特征在于:所述应用中,
反应温度为60℃~100℃,反应pH值为5.0~7.5,反应淫羊藿苷底物浓度为5~12mM;
淫羊藿苷和重组大肠杆菌KLUGIN73发酵液投料比为0.5~5g/L;
水解时间为2.5~5小时。
10.根据权利要求9所述的应用,其特征在于:所述应用中,
反应温度为80℃~100℃,反应pH值为5.5~7,反应淫羊藿苷底物浓度为8~10mM;
淫羊藿苷和重组大肠杆菌KLUGIN73发酵液投料比为1~3g/L;
水解时间为3~4小时。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210349185.1A CN114606173B (zh) | 2022-04-01 | 2022-04-01 | 重组大肠杆菌klugin73及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210349185.1A CN114606173B (zh) | 2022-04-01 | 2022-04-01 | 重组大肠杆菌klugin73及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114606173A true CN114606173A (zh) | 2022-06-10 |
CN114606173B CN114606173B (zh) | 2024-05-07 |
Family
ID=81866637
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210349185.1A Active CN114606173B (zh) | 2022-04-01 | 2022-04-01 | 重组大肠杆菌klugin73及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114606173B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108102936A (zh) * | 2018-02-26 | 2018-06-01 | 董颖军 | 乳酸克鲁维酵母突变株及其糖苷酶和应用 |
CN112226395A (zh) * | 2020-09-10 | 2021-01-15 | 广西大学 | 一株大肠杆菌工程菌及其全细胞催化产淫羊藿苷元的方法 |
CN114107341A (zh) * | 2021-11-29 | 2022-03-01 | 浙江熙正霖生物科技有限公司 | 真菌来源的α-L-鼠李糖苷酶在高效生产淫羊藿苷中的应用 |
-
2022
- 2022-04-01 CN CN202210349185.1A patent/CN114606173B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108102936A (zh) * | 2018-02-26 | 2018-06-01 | 董颖军 | 乳酸克鲁维酵母突变株及其糖苷酶和应用 |
CN112226395A (zh) * | 2020-09-10 | 2021-01-15 | 广西大学 | 一株大肠杆菌工程菌及其全细胞催化产淫羊藿苷元的方法 |
CN114107341A (zh) * | 2021-11-29 | 2022-03-01 | 浙江熙正霖生物科技有限公司 | 真菌来源的α-L-鼠李糖苷酶在高效生产淫羊藿苷中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN114606173B (zh) | 2024-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106995829B (zh) | 一种酶法转化淫羊藿总黄酮制备淫羊藿苷元的方法 | |
CN107641621B (zh) | 一种糖苷酶组合物及酶法制备淫羊藿苷元的方法 | |
CN109312375B (zh) | 一种橙皮素的制备方法、橙皮素中间体的制备方法和用于制备橙皮素的生物酶 | |
CN112210548A (zh) | 一种表达α-L-鼠李糖苷酶的毕赤酵母及其制备方法和应用 | |
CN113088528B (zh) | 一种α-L-鼠李糖苷酶突变酶的应用 | |
CN112322565A (zh) | 提高重组大肠杆菌中2’-岩藻糖基乳糖产量的方法 | |
CN110066777B (zh) | 一种内切菊粉酶及其在生产低聚果糖中的应用 | |
CN111944865B (zh) | 一种细菌来源的α-L-鼠李糖苷酶在高效生产橙皮素-7-O-葡萄糖苷中的应用 | |
CN108384769B (zh) | 一种耐高温复合酶及其应用 | |
CN103898177B (zh) | 制备高手性纯(r)-3-哌啶醇及其衍生物的方法 | |
CN108018252B (zh) | 一种中间体2’-脱氧鸟苷的制备方法 | |
CN114107341B (zh) | 真菌来源的α-L-鼠李糖苷酶在生产淫羊藿苷中的应用 | |
CN112442490B (zh) | 一种转化酶及其在产s-雌马酚中的应用 | |
CN109706189B (zh) | 一种d-手性肌醇的制备方法 | |
CN103898178B (zh) | 酶法制备高手性纯(s)-3-哌啶醇及其衍生物的方法 | |
CN116334041B (zh) | 一种鼠李糖苷酶突变体及其应用 | |
CN114606173A (zh) | 重组大肠杆菌klugin73及其应用 | |
CN114164224B (zh) | 一种低温脱苦酶的制备方法 | |
CN113736762B (zh) | 一种α-L-鼠李糖苷酶突变体及其在制备普鲁宁中的应用 | |
CN114921392B (zh) | 一种高效联产葡萄糖酸和蒜糖醇的方法 | |
WO2020050659A1 (ko) | 한천으로부터 당 알코올의 생물학적 신규 제조방법 | |
CN117778354B (zh) | 昆布多糖降解酶OUC-ScLam39突变体及其编码基因与应用 | |
CN112779235B (zh) | 一种生物催化合成多种黄酮苷的方法 | |
CN114478720B (zh) | 用于促进木质纤维素酶酶解的非催化蛋白基因及其非催化蛋白和应用 | |
CN113403332B (zh) | 一种α-琼胶酶基因及其编码酶的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |